BioLine Rx Ltd (BLRX)
0.68
+0.02
(+3.01%)
USD |
NASDAQ |
May 03, 16:00
0.6783
0.00 (0.00%)
After-Hours: 20:00
BioLine Rx Cash from Operations (Quarterly): 4.991M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.991M |
| September 30, 2023 | -9.901M |
| June 30, 2023 | -9.682M |
| March 31, 2023 | -8.016M |
| December 31, 2022 | -5.683M |
| September 30, 2022 | -8.682M |
| June 30, 2022 | -6.289M |
| March 31, 2022 | -5.586M |
| December 31, 2021 | -5.503M |
| September 30, 2021 | -5.013M |
| June 30, 2021 | -6.828M |
| March 31, 2021 | -6.229M |
| December 31, 2020 | -5.432M |
| September 30, 2020 | -5.471M |
| June 30, 2020 | -5.565M |
| March 31, 2020 | -6.738M |
| December 31, 2019 | -5.43M |
| September 30, 2019 | -6.169M |
| June 30, 2019 | -6.445M |
| March 31, 2019 | -4.622M |
| December 31, 2018 | -5.141M |
| September 30, 2018 | -6.011M |
| June 30, 2018 | -6.233M |
| March 31, 2018 | -6.807M |
| December 31, 2017 | -6.324M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.217M |
| June 30, 2017 | -4.213M |
| March 31, 2017 | -3.793M |
| December 31, 2016 | -4.085M |
| September 30, 2016 | -2.982M |
| June 30, 2016 | -3.262M |
| March 31, 2016 | -4.184M |
| December 31, 2015 | -3.188M |
| September 30, 2015 | -3.835M |
| June 30, 2015 | -3.677M |
| March 31, 2015 | -3.468M |
| December 31, 2014 | -4.773M |
| September 30, 2014 | -3.244M |
| June 30, 2014 | -4.342M |
| March 31, 2014 | -3.391M |
| December 31, 2013 | -3.855M |
| September 30, 2013 | -4.283M |
| June 30, 2013 | -6.134M |
| March 31, 2013 | -5.253M |
| December 31, 2012 | -6.769M |
| September 30, 2012 | -4.037M |
| June 30, 2012 | -5.830M |
| March 31, 2012 | -3.478M |
| December 31, 2011 | -4.040M |
| September 30, 2011 | -0.9679M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.901M
Minimum
Sep 2023
4.991M
Maximum
Dec 2023
-5.983M
Average
-6.169M
Median
Sep 2019
Cash from Operations (Quarterly) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | -3.649M |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -6.242M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -20.40M |
| Cash from Financing (Quarterly) | 11.74M |
| Free Cash Flow | -22.90M |
| Free Cash Flow Per Share (Quarterly) | 0.0692 |
| Free Cash Flow to Equity (Quarterly) | 6.736M |
| Free Cash Flow Yield | -52.45% |